Literature DB >> 21383166

A target for antiangiogenic therapy: vascular endothelium derived from glioblastoma.

Adília Hormigo1, Bi-Sen Ding, Shahin Rafii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21383166      PMCID： PMC3060236          DOI： 10.1073/pnas.1019656108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis.

Authors:  D H Ausprunk; J Folkman
Journal:  Microvasc Res       Date:  1977-07       Impact factor: 3.514

2.  Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

Authors:  Manish Aghi; Kenneth S Cohen; Rachael J Klein; David T Scadden; E Antonio Chiocca
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

Review 3.  Angiogenesis in gliomas: biology and molecular pathophysiology.

Authors:  Ingeborg Fischer; Jean-Pierre Gagner; Meng Law; Elizabeth W Newcomb; David Zagzag
Journal:  Brain Pathol       Date:  2005-10       Impact factor: 6.508

4.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Authors:  J Holash; P C Maisonpierre; D Compton; P Boland; C R Alexander; D Zagzag; G D Yancopoulos; S J Wiegand
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

5.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

Review 8.  Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.

Authors:  Farbod Shojaei; Napoleone Ferrara
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

9.  Cancer. A few to flip the angiogenic switch.

Authors:  Shahin Rafii; David Lyden
Journal:  Science       Date:  2008-01-11       Impact factor: 47.728

10.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

Authors:  Michele De Palma; Mary Anna Venneri; Rossella Galli; Lucia Sergi Sergi; Letterio S Politi; Maurilio Sampaolesi; Luigi Naldini
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743
View more
  9 in total

1.  Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Authors:  Alessandro Cama; Fabio Verginelli; Lavinia Vittoria Lotti; Francesco Napolitano; Annalisa Morgano; Andria D'Orazio; Michele Vacca; Silvia Perconti; Felice Pepe; Federico Romani; Francesca Vitullo; Filippo di Lella; Rosa Visone; Massimo Mannelli; Hartmut P H Neumann; Giancarlo Raiconi; Carlo Paties; Antonio Moschetta; Roberto Tagliaferri; Angelo Veronese; Mario Sanna; Renato Mariani-Costantini
Journal:  Acta Neuropathol       Date:  2013-08-18       Impact factor: 17.088

2.  Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.

Authors:  Yu Qin; Masamichi Takahashi; Kristopher Sheets; Horacio Soto; Jessica Tsui; Panayiotis Pelargos; Joseph P Antonios; Noriyuki Kasahara; Isaac Yang; Robert M Prins; Jonathan Braun; Lynn K Gordon; Madhuri Wadehra
Journal:  J Neurooncol       Date:  2017-06-09       Impact factor: 4.130

Review 3.  Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.

Authors:  Ali S Arbab
Journal:  Histol Histopathol       Date:  2012-05       Impact factor: 2.303

4.  Brain distribution of cediranib is limited by active efflux at the blood-brain barrier.

Authors:  Tianli Wang; Sagar Agarwal; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2012-02-08       Impact factor: 4.030

5.  Invariant delineation of nuclear architecture in glioblastoma multiforme for clinical and molecular association.

Authors:  Hang Chang; Ju Han; Alexander Borowsky; Leandro Loss; Joe W Gray; Paul T Spellman; Bahram Parvin
Journal:  IEEE Trans Med Imaging       Date:  2012-12-04       Impact factor: 10.048

6.  Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method.

Authors:  Marc Payton; Toni Jun; William Wayne; Dongyin Yu; Raffi Manoukian; Grace Chung; Nancy Zhang; Ji-Rong Sun; Paula Kaplan-Lefko; Sheila Scully; Gwyneth Van; Robert Radinsky; Richard Kendall; Jonathan Oliner; Angela Coxon
Journal:  Lab Invest       Date:  2014-09-22       Impact factor: 5.662

7.  The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yuping Li; Mengzhuo Hou; Guangyu Lu; Natalia Ciccone; Xingdong Wang; Hengzhu Zhang
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

8.  ETV2 mediates endothelial transdifferentiation of glioblastoma.

Authors:  Chengjian Zhao; Gustavo A Gomez; Yuwei Zhao; Yu Yang; Dan Cao; Jing Lu; Hanshuo Yang; Shuo Lin
Journal:  Signal Transduct Target Ther       Date:  2018-02-09

9.  Prominin 1/CD133 endothelium sustains growth of proneural glioma.

Authors:  Bi-Sen Ding; Daylon James; Rajiv Iyer; Ilaria Falciatori; Dolores Hambardzumyan; Su Wang; Jason M Butler; Sina Y Rabbany; Adília Hormigo
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.